A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OVF in Patients With Cancer and Breakthrough Pain
Latest Information Update: 31 May 2016
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 31 May 2016 New trial record